Hemostasis Diagnostics Market: By Product Type, By Test Type, By Technology, By End-User ), and Geography

Hemostasis Diagnostics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Region

Hemostasis Diagnostics Market size was valued at US$ 3.98 billion in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from a liquid state to a gelatinous state. Hemostasis is maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction.

Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried out to identify the hemostasis defects. The market is growing at a significant rate due to the rise in the prevalence of trauma conditions and various surgeries around the globe. Moreover, the rise in the prevalence of cardiovascular diseases, cancer, and diabetes is also expected to propel the market. Furthermore, acquisitions and mergers, collaborations, test approvals, and launchings are the strategies followed by the companies to increase their revenue share. For instance, in January 2017, Instrumentation Laboratory, a subsidiary of Werfen acquired Accriva Diagnostics for the expansion of its hemostasis testing portfolio. In addition, in June 2017, Grifols and Beckman Coulter entered into a distribution agreement for the distribution of Grifol hemostasis instruments, consumables, and reagents around the globe.

Hemostasis Diagnostics Market Key Developments:

In November 2016, Siemens Healthineers launched the CE-marked Atellica COAG 360 system, a high-volume specialty analyzer used in the hemostasis diagnostics

Download Free Sample

Hemostasis Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.1%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Hemostasis Diagnostics Market Dynamics

Increase in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.

North-America Got Significant Share of

Hemostasis Diagnostics Market Regional Analysis

North America hemostasis diagnostics market growing at a significant rate due to well-developed healthcare infrastructure, the rise in prevalence of cardiovascular diseases (according to Centers for Disease Control and Prevention, approximately 610,000 deaths are observed due to cardiovascular diseases every year), an increase in awareness about hemostasis diagnostics are anticipated to fuel the market. Europe market driven by adoption of newer test methods in hemostasis diagnostics, increase in the prevalence of hemostasis condition (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), and changes in lifestyle leads to increase in prevalence of CVDs and diabetes, which are expected to propel the market. Asia Pacific market is growing due to increase in R&D activities in Asia Pacific countries such as Japan, and improving technical capabilities. Latin America market has a prominent growth due to increase in foreign investment, development in economic growth. Middle East and Africa market is driven by an increase in the prevalence of hemostasis and other clotting diseases in African countries

Latin America

Europe

Asia Pacific

Middle East

North America

Hemostasis Diagnostics Market Segmentation Analysis

Report Benchmarks	Details
Report Study Period	2024-2030
Market Size in 2023	US$ 3.98 billion
Market CAGR	9.1%
By Product Type	Systems, Consumables, Point-of-Care Testing Devices
By Test Type	Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests
By Technology	Optical, Mechanical, Electrochemical, Others
By End User	Hospitals, Clinics, Diagnostic Centres, Others (POC)

Key Features of the Report

The hemostasis diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The report tracks recent innovations, key developments, and start-up details that are actively working in the market
The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The hemostasis diagnostics market size was valued at US$ 3.98 billion in 2023 and is poised to grow at a CAGR of 9.1% from 2024-2030

Hoffmann-La Roche Ltd, Sysmex Corporation, Abbott Laboratories, Nihon Kohden Corporation, Siemens, Healthineers, Grifols S.A, Beckman Coulter, Inc.

North America is the fastest-growing region for the hemostasis diagnostics market

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary

2.Global Hemostasis Diagnostics Market Introduction

2.1.Global Hemostasis Diagnostics Market - Taxonomy

2.2.Global Hemostasis Diagnostics Market - Definitions

2.2.1.Product Type

2.2.2.Test Type

2.2.3.Technology

2.2.4.End User

2.2.5.End User

3.Global Hemostasis Diagnostics Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Product Landscape

3.6. New Product Launches

3.7. Impact of COVID 19 on Market

4.Global Hemostasis Diagnostics Market Analysis, 2019-2023 and Forecast 2024-2030

4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5.Global Hemostasis Diagnostics Market By Product Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

5.1. Systems,

5.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Consumables,

5.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

5.3. Point-of-Care Testing Devices

5.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

6.Global Hemostasis Diagnostics Market By Test Type, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

6.1. Fibrinogen Test,

6.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Activated Clotting Time,

6.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Platelet Function,

6.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Prothrombin Time,

6.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

6.5. Heparin & Protamine Dose-Response Test For ACT,

6.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.5.3. Market Opportunity Analysis

6.6. Activated Partial Thromboplastin Time,

6.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.6.3. Market Opportunity Analysis

6.7. Anti-Factor Xa,

6.7.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.7.3. Market Opportunity Analysis

6.8. Other Coagulation Tests

6.8.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.8.3. Market Opportunity Analysis

7.Global Hemostasis Diagnostics Market By Technology, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

7.1. Optical,

7.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Mechanical,

7.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Electrochemical,

7.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Others

7.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

8.Global Hemostasis Diagnostics Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

8.1. Hospitals,

8.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.1.3. Market Opportunity Analysis

8.2. Clinics,

8.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.2.3. Market Opportunity Analysis

8.3. Diagnostic Centres,

8.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.3.3. Market Opportunity Analysis

8.4. Others (POC)

8.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

8.4.3. Market Opportunity Analysis

9.Global Hemostasis Diagnostics Market By End User, 2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

9.1. Hospitals,

9.1.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.1.3. Market Opportunity Analysis

9.2. Pharmaceutical Companies,

9.2.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.2.3. Market Opportunity Analysis

9.3. Food And Beverages Companies,

9.3.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.3.3. Market Opportunity Analysis

9.4. Medical Devices Companies,

9.4.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.4.3. Market Opportunity Analysis

9.5. Research Institutes,

9.5.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.5.3. Market Opportunity Analysis

9.6. Others

9.6.1. Market Analysis, 2019-2023 and Forecast, 2024-2030, (Sales Value USD Million)

9.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

9.6.3. Market Opportunity Analysis

10.Hospitals, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

10.1. Product Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.1.1.Systems,

10.1.2.Consumables,

10.1.3.Point-of-Care Testing Devices

10.2. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.2.1.Fibrinogen Test,

10.2.2.Activated Clotting Time,

10.2.3.Platelet Function,

10.2.4.Prothrombin Time,

10.2.5.Heparin & Protamine Dose-Response Test For ACT,

10.2.6.Activated Partial Thromboplastin Time,

10.2.7.Anti-Factor Xa,

10.2.8.Other Coagulation Tests

10.3. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.3.1.Optical,

10.3.2.Mechanical,

10.3.3.Electrochemical,

10.3.4.Others

10.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.4.1.Hospitals,

10.4.2.Clinics,

10.4.3.Diagnostic Centres,

10.4.4.Others (POC)

10.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

10.5.1.United States of America (USA)

10.5.2.Canada

11.Pharmaceutical Companies, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.1.1.Systems,

11.1.2.Consumables,

11.1.3.Point-of-Care Testing Devices

11.2. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.2.1.Fibrinogen Test,

11.2.2.Activated Clotting Time,

11.2.3.Platelet Function,

11.2.4.Prothrombin Time,

11.2.5.Heparin & Protamine Dose-Response Test For ACT,

11.2.6.Activated Partial Thromboplastin Time,

11.2.7.Anti-Factor Xa,

11.2.8.Other Coagulation Tests

11.3. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.3.1.Optical,

11.3.2.Mechanical,

11.3.3.Electrochemical,

11.3.4.Others

11.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.4.1.Hospitals,

11.4.2.Clinics,

11.4.3.Diagnostic Centres,

11.4.4.Others (POC)

11.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

11.5.1.Germany

11.5.2.France

11.5.3.Italy

11.5.4.United Kingdom (UK)

11.5.5.Spain

11.5.6.Rest of EU

11.5.7.

12.Food And Beverages Companies, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.1.1.Systems,

12.1.2.Consumables,

12.1.3.Point-of-Care Testing Devices

12.2. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.2.1.Fibrinogen Test,

12.2.2.Activated Clotting Time,

12.2.3.Platelet Function,

12.2.4.Prothrombin Time,

12.2.5.Heparin & Protamine Dose-Response Test For ACT,

12.2.6.Activated Partial Thromboplastin Time,

12.2.7.Anti-Factor Xa,

12.2.8.Other Coagulation Tests

12.3. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.3.1.Optical,

12.3.2.Mechanical,

12.3.3.Electrochemical,

12.3.4.Others

12.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.4.1.Hospitals,

12.4.2.Clinics,

12.4.3.Diagnostic Centres,

12.4.4.Others (POC)

12.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

12.5.1.China

12.5.2.India

12.5.3.Australia and New Zealand (ANZ)

12.5.4.Japan

12.5.5.Rest of APAC

13.Medical Devices Companies, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.1.1.Systems,

13.1.2.Consumables,

13.1.3.Point-of-Care Testing Devices

13.2. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.2.1.Fibrinogen Test,

13.2.2.Activated Clotting Time,

13.2.3.Platelet Function,

13.2.4.Prothrombin Time,

13.2.5.Heparin & Protamine Dose-Response Test For ACT,

13.2.6.Activated Partial Thromboplastin Time,

13.2.7.Anti-Factor Xa,

13.2.8.Other Coagulation Tests

13.3. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.3.1.Optical,

13.3.2.Mechanical,

13.3.3.Electrochemical,

13.3.4.Others

13.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.4.1.Hospitals,

13.4.2.Clinics,

13.4.3.Diagnostic Centres,

13.4.4.Others (POC)

13.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

13.5.1.GCC Countries

13.5.2.South Africa

13.5.3.Rest of MEA

14.Research Institutes, Hemostasis Diagnostics Market ,2019-2023 and Forecast 2024-2030 (Sales Value USD Million)

14.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

14.1.1.Systems,

14.1.2.Consumables,

14.1.3.Point-of-Care Testing Devices

14.2. Test Type Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

14.2.1.Fibrinogen Test,

14.2.2.Activated Clotting Time,

14.2.3.Platelet Function,

14.2.4.Prothrombin Time,

14.2.5.Heparin & Protamine Dose-Response Test For ACT,

14.2.6.Activated Partial Thromboplastin Time,

14.2.7.Anti-Factor Xa,

14.2.8.Other Coagulation Tests

14.3. Technology Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

14.3.1.Optical,

14.3.2.Mechanical,

14.3.3.Electrochemical,

14.3.4.Others

14.4. End User Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

14.4.1.Hospitals,

14.4.2.Clinics,

14.4.3.Diagnostic Centres,

14.4.4.Others (POC)

14.5. Country Analysis 2019-2023 and Forecast 2024-2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%)

14.5.1.Brazil

14.5.2.Mexico

14.5.3.Rest of LA

15. Competition Landscape

15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis)

15.2.1.Hoffmann-La Roche Ltd. (Switzerland)

15.2.2.Sysmex Corporation (Japan)

15.2.3.Abbott Laboratories (U.S.)

15.2.4.Alere Inc. (U.S.)

15.2.5.Nihon Kohden Corporation (Japan)

15.2.6.Siemens Healthineers (Germany)

15.2.7.Grifols S.A (Spain)

15.2.8.Beckman Coulter, Inc. (U.S.)

16. Research Methodology

17. Appendix and Abbreviations

Key Market Players

Hoffmann-La Roche Ltd. (Switzerland)
Sysmex Corporation (Japan)
Abbott Laboratories (U.S.)
Alere Inc. (U.S.)
Nihon Kohden Corporation (Japan)
Siemens Healthineers (Germany)
Grifols S.A (Spain)
Beckman Coulter, Inc. (U.S.)

Related Industry Reports

Middle East And Africa Hemostasis Diagnostics Market

Latin America Hemostasis Diagnostics Market

North America Hemostasis Diagnostics Market

Europe Hemostasis Diagnostics Market